Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
Year: 2007
Type: article
Source: The Lancet
Author: Kevin A. Ault
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: GlaxoSmithKline, Merck
OpenAlex ID: W2142200682